101d

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
The X-ray crystal structure of the complex of the B-DNA dodecamer, CGCGAATTCGCG with the antitumor drug netropsin has been reexamined to, locate the drug accurately for computer-based drug design. The optimum, solution is with the drug centered in the AATT region of the minor groove, making three good bifurcated hydrogen bonds with adenine N3 and thymine O2, atoms along the floor of the groove. Pyrrole rings of netropsin are packed, against the C2 positions of adenines, leaving no room for the amine group, of guanine and, hence, providing a structural rationale for the A.T, specificity of netropsin. An alternative positioning in which the drug is, shifted along the minor groove by ca. one-half base pair step is rejected, on the basis of free R factor calculations and the appearance of the, original drug-free difference maps. Final omit maps, although of more, pleasing appearance, are not a dependable means of discriminating between, right and wrong structures. The shifted alternative drug position ignores, potential hydrogen bonding along the floor of the groove, provides no, explanation for netropsin's observed A.T specificity, and is contradicted, by NMR results [Patel, D. J. (1982) Proc. Natl. Acad. Sci. U.S.A. 79, 6424].
+
The X-ray crystal structure of the complex of the B-DNA dodecamer CGCGAATTCGCG with the antitumor drug netropsin has been reexamined to locate the drug accurately for computer-based drug design. The optimum solution is with the drug centered in the AATT region of the minor groove, making three good bifurcated hydrogen bonds with adenine N3 and thymine O2 atoms along the floor of the groove. Pyrrole rings of netropsin are packed against the C2 positions of adenines, leaving no room for the amine group of guanine and, hence, providing a structural rationale for the A.T specificity of netropsin. An alternative positioning in which the drug is shifted along the minor groove by ca. one-half base pair step is rejected on the basis of free R factor calculations and the appearance of the original drug-free difference maps. Final omit maps, although of more pleasing appearance, are not a dependable means of discriminating between right and wrong structures. The shifted alternative drug position ignores potential hydrogen bonding along the floor of the groove, provides no explanation for netropsin's observed A.T specificity, and is contradicted by NMR results [Patel, D. J. (1982) Proc. Natl. Acad. Sci. U.S.A. 79, 6424].
==About this Structure==
==About this Structure==
Line 12: Line 12:
Refinement of netropsin bound to DNA: bias and feedback in electron density map interpretation., Goodsell DS, Kopka ML, Dickerson RE, Biochemistry. 1995 Apr 18;34(15):4983-93. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=7711020 7711020]
Refinement of netropsin bound to DNA: bias and feedback in electron density map interpretation., Goodsell DS, Kopka ML, Dickerson RE, Biochemistry. 1995 Apr 18;34(15):4983-93. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=7711020 7711020]
[[Category: Protein complex]]
[[Category: Protein complex]]
-
[[Category: Dickerson, R.E.]]
+
[[Category: Dickerson, R E.]]
-
[[Category: Goodsell, D.S.]]
+
[[Category: Goodsell, D S.]]
-
[[Category: Kopka, M.L.]]
+
[[Category: Kopka, M L.]]
[[Category: MG]]
[[Category: MG]]
[[Category: NT]]
[[Category: NT]]
Line 22: Line 22:
[[Category: modified]]
[[Category: modified]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 15:27:44 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 11:37:16 2008''

Revision as of 09:37, 21 February 2008


101d, resolution 2.250Å

Drag the structure with the mouse to rotate

REFINEMENT OF NETROPSIN BOUND TO DNA: BIAS AND FEEDBACK IN ELECTRON DENSITY MAP INTERPRETATION

Overview

The X-ray crystal structure of the complex of the B-DNA dodecamer CGCGAATTCGCG with the antitumor drug netropsin has been reexamined to locate the drug accurately for computer-based drug design. The optimum solution is with the drug centered in the AATT region of the minor groove, making three good bifurcated hydrogen bonds with adenine N3 and thymine O2 atoms along the floor of the groove. Pyrrole rings of netropsin are packed against the C2 positions of adenines, leaving no room for the amine group of guanine and, hence, providing a structural rationale for the A.T specificity of netropsin. An alternative positioning in which the drug is shifted along the minor groove by ca. one-half base pair step is rejected on the basis of free R factor calculations and the appearance of the original drug-free difference maps. Final omit maps, although of more pleasing appearance, are not a dependable means of discriminating between right and wrong structures. The shifted alternative drug position ignores potential hydrogen bonding along the floor of the groove, provides no explanation for netropsin's observed A.T specificity, and is contradicted by NMR results [Patel, D. J. (1982) Proc. Natl. Acad. Sci. U.S.A. 79, 6424].

About this Structure

101D is a Protein complex structure of sequences from [1] with and as ligands. Full crystallographic information is available from OCA.

Reference

Refinement of netropsin bound to DNA: bias and feedback in electron density map interpretation., Goodsell DS, Kopka ML, Dickerson RE, Biochemistry. 1995 Apr 18;34(15):4983-93. PMID:7711020

Page seeded by OCA on Thu Feb 21 11:37:16 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools